Invention Grant
US09402844B2 Methods of modulating drug plasma levels using erythrohydroxybupropion
有权
使用红羟基安非他酮调节药物血浆水平的方法
- Patent Title: Methods of modulating drug plasma levels using erythrohydroxybupropion
- Patent Title (中): 使用红羟基安非他酮调节药物血浆水平的方法
-
Application No.: US14628062Application Date: 2015-02-20
-
Publication No.: US09402844B2Publication Date: 2016-08-02
- Inventor: Herriot Tabuteau
- Applicant: Antecip Bioventures II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Brent A. Johnson; Louis C. Cullman
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K31/485 ; A61K31/4748 ; A61K31/138
Abstract:
This disclosure relates to methods administering erythrohydroxybupropion or a prodrug thereof in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan or dextrorphan and erythrohydroxybupropion or a prodrug of erythrohydroxybupropion are also disclosed
Public/Granted literature
- US20150157582A1 METHODS OF MODULATING DRUG PLASMA LEVELS USING ERYTHROHYDROXYBUPROPION Public/Granted day:2015-06-11
Information query
